Skip to content
Main Menu
  • Company
      • Leadership
      • Partnerships
      • Sustainability
      • Medical Educational Grants
      • Investigator sponsored trials
  • Portfolio
      • Portfolio
      • Aesthetics Pipeline
      • Therapeutics pipeline
      • Clinical highlights
  • Careers
      • Opportunities
      • Culture
      • Privacy Notice
  • News
      • Media
      • Press Release
  • Contact Us
LOGIN
Main Menu
  • Company
    • Leadership
    • Partnerships
    • Sustainability
    • Medical Educational Grants
    • Investigator Sponsored Trials
  • Portfolio
    • Portfolio
    • Aesthetics Pipeline
    • Therapeutics Pipeline
    • Clinical Highlights
  • Careers
    • Opportunities
    • Culture
    • Privacy Notice
  • News
    • Media
    • Press Release
  • Contact Us

Press Release

Press Inquiries Contact
ICR
Revance@icrinc.com

Main Menu
  • Media
  • Press Release
  • 31
  • March
  • 2025

Crown Laboratories Now Operates Under the Name Revance

LEARN MORE
  • 06
  • February
  • 2025

Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics

LEARN MORE
Company
  • Leadership
  • Partnerships
  • Sustainability
  • Medical Education Grants
  • Investigator Sponsored Trials
  • California Compliance Declaration
  • Contact Us
Portfolio
  • Products
  • Aesthetics Pipeline
  • Therapeutics Pipeline
  • Clinical Highlights
Careers
  • Opportunities
  • Culture
  • Privacy Notice
News
  • Media
  • Press Release
Company
  • LEADERSHIP
  • PARTNERSHIPS
  • SUSTAINABILITY
  • MEDICAL EDUCATION GRANTS
  • INVESTIGATOR SPONSORED TRIALS
  • CALIFORNIA COMPLIANCE DECLARATION
  • CONTACT US
Portfolio
  • PORTFOLIO
  • AESTHETICS PIPELINE
  • THERAPEUTICS PIPELINE
  • CLINICAL HIGHLIGHTS
Careers
  • OPPORTUNITIES
  • CULTURE
  • PRIVACY NOTICE
News
  • MEDIA
  • PRESS RELEASE
Facebook-f Instagram Twitter Linkedin-in

For customer service, product information, new accounts or adverse events call: 877-3REV-NOW

1222 Demonbreun St
20th Floor
Nashville, TN 37203

©2025 Revance Therapeutics, Inc.
RHA® and RHA Redensity® are registered trademarks of TEOXANE SA, manufactured in Switzerland. The Teoxane RHA® Collection is exclusively distributed by Revance®. All other trademarks are the property of their respective owners.
CORP-00147

  • Social Media Community Guidelines
  • Privacy Policy
  • Terms of Use
  • Social Media Community Guidelines
  • Privacy Policy
  • Terms of Use